@KarlGaffney1: extra-articular manifestations (EAMs) were present in 30% of people with #axialSpA in BSRBR-AS. EAMs did not appear to influence decision to prescribe 1st biologic but uveitis and IBD did influence which TNFi was chosen (i.e.monoclonal TNFi) #EULAR2019 https://t.co/3qSEPIvoxF